32 Biosciences vs Amgen
32 Biosciences vs Amgen, compared side by side on 21 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: 32 Biosciences is on 42/100 and Amgen on 34/100.
Where each one leads
32 Biosciences
- our overall score: 42/100 against 34/100
Amgen
- agent readiness: 41/100 against 21/100
- domain rating: 80/100 against 13/100
- headcount: 39,919 against 9
- funding raised: $40.0M against $12.0M
- LinkedIn following: 1,697,311 against 926
At a glance
| Measure | 32 Biosciences | Amgen |
|---|---|---|
| What it is | Develops novel therapeutic antibodies for oncology and autoimmune diseases. | A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics. |
| Category | Biotech, Drug Discovery, Oncology, Autoimmune Diseases | Biotech, MedTech, HealthTech, Genomics |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | 2017 | 1980 |
| Headquarters | San Diego, United States | Thousand Oaks, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | 32 Biosciences | Amgen |
|---|---|---|
| Employees | 9 | 39,919 |
| Total funding | $12.0M | $40.0M |
| Latest round | Not published | IPO |
| LinkedIn followers | 926 | 1,697,311 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | 32 Biosciences | Amgen |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 42/100 | 34/100 |
| Traction | 45/100 | 58/100 |
| Team | 30/100 | 70/100 |
| Community | 3/100 | 8/100 |
| Search visibility | 24/100 | 68/100 |
| Quality | 48/100 | 15/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | D (41/100) |
| Domain ratingLink authority, 0-100 | 13/100 | 80/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | 32 Biosciences | Amgen |
|---|---|---|
| Hosting | Self Managed | AWS |
| CDN | Not detected | CloudFront |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Bootstrap |
| Analytics | Google Analytics 4 | Google Tag Manager |
What users say
| Measure | 32 Biosciences | Amgen |
|---|---|---|
| Community ratingVisitor votes on StartupHub | 1.0/5 from 1 vote | Not published |
32 Biosciences vs Amgen: common questions
Which is better, 32 Biosciences or Amgen?
On our 0-100 score 32 Biosciences rates higher (42/100 against 34/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 21 data points above: read the rows that match what you are buying for.
How do 32 Biosciences and Amgen compare on the numbers?
32 Biosciences leads on our overall score (42/100 against 34/100). Amgen leads on agent readiness (41/100 against 21/100), domain rating (80/100 against 13/100), headcount (39,919 against 9), funding raised ($40.0M against $12.0M), LinkedIn following (1,697,311 against 926).
Read the full 32 Biosciences review and pricing or the Amgen review and pricing. You can also browse other 32 Biosciences alternatives we track.